Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$640M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$501M |
| 3 |
Digital Realty Trust
DLR
|
+$438M |
| 4 |
Intuitive Surgical
ISRG
|
+$437M |
| 5 |
Amazon
AMZN
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$545M |
| 2 |
DexCom
DXCM
|
+$457M |
| 3 |
AT&T
T
|
+$431M |
| 4 |
Palo Alto Networks
PANW
|
+$416M |
| 5 |
Humana
HUM
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.03% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 1.99% |
| 4 | Financials | 1.93% |
| 5 | Industrials | 1.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11901
CALL
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$923M
| $43.1K | ﹤0.01% |
+1,000
| New | +$43.5K |
|
|
11902
PUT
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$923M
| $43.1K | ﹤0.01% |
+1,000
| New | +$43.5K |
|
|
AUTL
11903
CALL
Autolus Therapeutics
AUTL
$572M
| $43.1K | ﹤0.01% |
18,100
-9,100
| -33% | -$21.6K |
|
11904
Rail Vision
RVSN
$11.3M
| $43K | ﹤0.01% |
+352
| New | +$66.4K |
|
|
DESP
11905
PUT
DELISTED
Despegar.com
DESP
| $43K | ﹤0.01% |
6,100
-1,400
| -19% | -$8.6K |
|
|
ARAV
11906
CALL
DELISTED
Aravive, Inc. Common Stock
ARAV
| $43K | ﹤0.01% |
34,100
-54,000
| -61% | -$87.6K |
|
11907
CALL
Caribou Biosciences
CRBU
$169M
| $42.9K | ﹤0.01% |
10,100
+4,100
| +68% | +$18.4K |
|
11908
PUT
H.B. Fuller
FUL
$3.38B
| $42.9K | ﹤0.01% |
600
-14,100
| -96% | -$926K |
|
11909
PUT
Liquidity Services
LQDT
$1.36B
| $42.9K | ﹤0.01% |
2,600
+2,100
| +420% | +$30.8K |
|
11910
Coya Therapeutics
COYA
$112M
| $42.9K | ﹤0.01% |
+10,537
| New | +$48.9K |
|
|
WCN
11911
PUT
Waste Connections
WCN
$41.8B
| $42.9K | ﹤0.01% |
300
-13,200
| -98% | -$1.84M |
|
11912
PUT
Smartbird Inc
BIRD
$30.1M
| $42.8K | ﹤0.01% |
1,700
-1,065
| -39% | -$26.6K |
|
11913
CALL
ADMA Biologics
ADMA
$2.12B
| $42.8K | ﹤0.01% |
11,600
-2,900
| -20% | -$10.7K |
|
|
UROY
11914
CALL
Uranium Royalty Corp
UROY
$1.57B
| $42.8K | ﹤0.01% |
21,400
+13,700
| +178% | +$27.3K |
|
11915
CALL
Horizon Kinetics Inflation Beneficiaries ETF
INFL
$1.55B
| $42.8K | ﹤0.01% |
1,400
-6,500
| -82% | -$199K |
|
11916
CALL
AnaptysBio
ANAB
$1.73B
| $42.7K | ﹤0.01% |
2,100
+1,700
| +425% | +$34.5K |
|
11917
Genworth Financial
GNW
$3.84B
| $42.7K | ﹤0.01% |
8,537
-161,759
| -95% | -$885K |
|
11918
PUT
CTS Corp
CTS
$1.81B
| $42.6K | ﹤0.01% |
1,000
+900
| +900% | +$39.6K |
|
|
SACH
11919
Sachem Capital Corp
SACH
$37.9M
| $42.6K | ﹤0.01% |
+12,204
| New | +$41.2K |
|
11920
National Grid
NGG
$81.5B
| $42.6K | ﹤0.01% |
+671
| New | +$44K |
|
11921
PUT
Phibro Animal Health
PAHC
$1.39B
| $42.5K | ﹤0.01% |
3,100
-800
| -21% | -$11.5K |
|
11922
PUT
Hackett Group
HCKT
$265M
| $42.5K | ﹤0.01% |
1,900
-2,600
| -58% | -$50.9K |
|
11923
CALL
IBEX
IBEX
$480M
| $42.5K | ﹤0.01% |
+2,000
| New | +$42.8K |
|
11924
CALL
NRX Pharmaceuticals
NRXP
$140M
| $42.4K | ﹤0.01% |
8,770
-60
| -0.7% | -$361 |
|
11925
CALL
Fate Therapeutics
FATE
$308M
| $42.4K | ﹤0.01% |
8,900
-12,600
| -59% | -$69.5K |
|
Similar funds
Ken Griffin's Q2 2023 Portfolio in Review
As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.
- Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
- Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
- Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
- Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
- Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
- Ken Griffin opened 1,205 new positions and closed 1,562 in Q2 2023.
- Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.
Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.